Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Keeping Track: CDER 2016 Novel Approvals Hold At 22 As US FDA Declines Cempra's Solithera

Dec 30 2016

• By Bridget Silverman

Related Content

Jardiance's Cardiovascular Benefit Claim Bodes Well For Other Products Too

Dec 05 2016

Do FDA Submission, Approval Declines Outside Cancer Signal Future Treatment Gaps?

Dec 15 2016

<em>Primatene</em> OTC Asthma Inhaler Amended NDA Expected Second Quarter

Apr 04 2016

CBER Approvals Hit A High Note For Director Midthun's Swan Song

Jan 11 2016

Big Pharma's Winning Formula: Many Approvals, Narrow Markets

Jan 04 2016

Cempra's Solithera Draws FDA Complete Response Letter On Liver Risks

Dec 29 2016

Related Companies

Melinta Therapeutics, Inc.

Amphastar Pharmaceuticals, Inc.

Wockhardt Limited

Hospira, Inc.

Armstrong Medical Ltd.

Boehringer Ingelheim GmbH

Additional Topics

United States Approvals Complete Response Letters Regulation BioPharmaceutical

More from Approvals

More from Product Reviews

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window